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Abstract
Background: Aspergillus fumigatus is associated with both invasive and allergic pulmonary diseases, in different hosts. The
organism is inhaled as a spore, which, if not cleared from the airway, germinates into hyphal morphotypes that are
responsible for tissue invasion and resultant inflammation. Hyphae secrete multiple products that function as antigens,
evoking both a protective (TH1–TH17) and destructive allergic (TH2) immunity. How Aspergillus allergens (Asp f proteins)
participate in the development of allergic sensitization is unknown.
Methodology/Principal Findings: To determine whether Asp f proteins are strictly associated with TH2 responses, or
represent soluble hyphal products recognized by healthy hosts, human T cell responses to crude and recombinant products
were characterized by ELISPOT. While responses (number of spots producing IFN-c, IL-4 or IL-17) to crude hyphal antigen
preparations were weak, responses to recombinant Asp f proteins were higher. Recombinant allergens stimulated cells to
produce IFN-c more so than IL-4 or IL-17. Volunteers exhibited a diverse CD4+ and CD8+ T cell antigen recognition profile,
with prominent CD4 TH1-responses to Asp f3 (a putative peroxismal membrane protein), Asp f9/16 (cell wall glucanase), Asp
f11 (cyclophilin type peptidyl-prolyl isomerase) and Asp f22 (enolase). Strong IFN-c responses were reproduced in most
subjects tested over 6 month intervals.
Conclusions: Products secreted after conidial germination into hyphae are differentially recognized by protective T cells in
healthy, non-atopic individuals. Defining the specificity of the human T cell repertoire, and identifying factors that govern
early responses may allow for development of novel diagnostics and therapeutics for both invasive and allergic Aspergillus
diseases.
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Introduction
While our airways are exposed to the ubiquitous Aspergillus
fumigatus (Af) constantly, only a subset of people develop
complications; pulmonary manifestations fall into a spectrum of
hypersensitivity respiratory disorders (Aspergillus induced asthma,
allergic bronchopulmonary aspergillosis, allergic Aspergillus sinus-
itis, and hypersensitivity pneumonitis) to more invasive syndromes
(pulmonary aspergillosis, disseminated disease). The immuno-
pathogenesis of disease, and the nature of pulmonary host
defenses- essentially, what defines the balance between destructive
and protective inflammatory responses- are becoming better
defined. The organism, inhaled as an inert, chitinous spore that
is covered with hydrophobins, will germinate into germ tube and
hyphal morphotypes if not cleared by resident phagocytic cells.
Germination- and loss of the hydrophobin layer- results in
exposure of b-glucan, a ligand for dectin-1, resulting in stimulation
of inflammatory cytokines from macrophages and activation of
specific maturation phenotypes on dendritic cells (DC) [1–5].
Hyphal morphotypes secrete multiple soluble products that are
involved in microbial adaptation to the local environment (e.g.
proteases, etc.). Effector phagocytes (neutrophils) are responsible
for clearing hyphae; a subsequent T-lymphocyte response is
triggered by DC traveling to lymph nodes for presentation of
pathogen-produced antigens to naı ¨ve T cells. Thus, cells of innate
immunity both function to clear the organism from the airways,
and to initiate memory T cell responses. These CD4+ T
lymphocyte responses can be both protective, with T-helper 1
(TH1) and TH17 phenotypes, and pathologic, with a predominant
TH2 phenotype driving allergic inflammation.
What dictates generation of TH1–TH17 or TH2 immunity is
becoming more understood, with results of recent studies outlining
the pivotal role of microbial adjuvants in tailoring the activating
phenotypes on antigen presenting cells. DC stimulated through
dectin-1 activate CD4+ TH1 and TH17 cells [5]; similarly, DC
that are stimulated via dectin-1 efficiently prime cytotoxic T cells
[6]. Other microbial adjuvants, such as chitin, alternatively
activate macrophages to drive TH2 immunity [7]. The nature of
the protein antigen recognized likely also serve to promote a
specific inflammatory phenotype; recent studies have shown that
basophils serve as antigen presenting cells to augment TH2
immunity, particularly in response to soluble proteases [8,9].
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immunity and allergic inflammation, and several secreted
‘allergens’ have been described. These proteins, also called ‘‘Asp
f’’ proteins, were largely identified as proteins recognized by CD4+
TH2 cells or IgE in allergic individuals. Homology-based sequence
analyses indicate that these gene products include proteases,
peptidases, and glucanases. It has been assumed that these proteins
naturally evoke TH2 immune responses, with specific ‘‘allergenic’’
potential (thus the ‘‘Asp f’’ designations). However, these products
also preferentially represent those that are abundantly expressed by
the hyphal form of the organism, likely reflecting their activity in
stress response and adaptation to the local environment [10]. We
hypothesized that the Asp f proteins are not strictly functioning as
allergens, but are the soluble Aspergillus products that are most
abundantly recognized in the host after exposure to metabolically
active hyphae. Answering this question is important both to our
understanding of the immunopathogenesis of allergic diseases and
to the development of assays to enable measurement of organism
specific immune reconstitution. To address this, T cell responses to
crude A. fumigatus hyphal antigens, and specific recombinant Asp f
antigens were characterized in a cohort of healthy human
volunteers. Results demonstrate that peripheral blood from healthy
human volunteers contain CD4+ and CD8+ T cells with specificity
to multiple hyphal-secreted antigens previously identified as
allergens. These findings are consistent with the current paradigm
in which efficacy of airway conidial clearance, and the nature of
local inflammatory responses tailor induction and maintenance of
specific immunity, not exposure to specific Aspergillus allergens.
Results
Expression of Recombinant Asp f Proteins
Multiple proteins have been described as ‘‘Asp f’’ allergens;
these entries were tabulated from www.allergen.org, with
homology based sequence comparison to more fully characterize
the open reading frame and assign putative functions. In this
analysis, we found that the allergens previously described as Asp f9
and Asp f16 corresponded to the same open reading frame (ORF).
Multiple attempts to clone the cDNA for allergen Asp f16 were
made, without success. Sequence information at GenBank
(accession number AF062651) was used to generate oligonucleo-
tides to amplify by PCR the entire cDNA for Asp f16 from the A.
fumigatus sequenced strain, Af293 [11] and from the strain used by
Banerjee, et al. (AF-102, ATCC 42202) in the original Asp f16
cloning [12]. Four and five independent clones from Af293 and
ATCC 42202, respectively, were sequenced and found to be
identical to the Asp f9 sequence (GenBank accession number
AJ223327; this is a partial clone), now annotated as the cell wall
glucanase Crf1 by TIGR (http://www.tigr.org/tdb/e2k1/afu1/
afu1.shtml; genome locus AFUA_1G16190). Oligonucleotides
designed with Asp f9 sequence information from TIGR only
yielded Asp f9 cDNA PCR amplicons from ATCC 42202 cDNA.
Hence, the product Asp f 9 is the same as Asp f 16, as designated
here as Asp f9/16.
Either partial, or complete ORFs for cloning into the E. coli
expression system were amplified (Table 1). Out of 17 proteins,
eight were not expressed and one, Asp f1, a potent ribotoxin, could
not be successfully cloned downstream of the trp-lac promoter,
although the plasmid vector harbors the lacI
q repressor gene to
maintain regulation of the promoter in the absence of inducer.
Upon closer examination of the deduced function of Asp f4, 5, 7,
8, 10, 13, and 18, four have been ascribed as proteases and the
remaining proteins have unknown function (Table 1, gray shaded
proteins). Multiple attempts to express these recombinant proteins
were not successful, suggesting that these proteins were deleterious
and or toxic to E. coli using the pTrcHis2 expression system. High
level expression of Asp f2 was not achieved in this system even
after induction in BL21(DE3) E. coli (Invitrogen) to minimize
Table 1. Asp f proteins.
Allergen GenBank entry Calculated size Genomic locus Putative function
Asp f1* M83781 19.6 kDa Afu5g02330 major allergen I; ribotoxin
Asp f2 U56938 32.8 kDa Afu4g09580 allergen 2
Asp f3 U58050 18.4 kDa Afu6g02280 peroxisomal membrane protein
Asp f4 AJ00173 30.0 kDa (34.0 kDa)# Afu2g03830 allergen 4
Asp f5 Z30424 68.7 kDa Afu8g07080 metalloprotease (MEP)
Asp f6 U53561 23.4 kDa Afu1g14550 manganese superoxide dismutase
Asp f7 AJ223315 11.6 kDa (27.5 kDa) Afu4g06670 allergen 7
Asp f8 AJ224333 11.1 kDa Afu2g10100 acidic ribosomal protein P2
Asp f9/16 AJ223327 32.3 kDa (40.2 kDa) Afu1g16190 cell wall glucanase Crf1
Asp f10 X85092 41.6 kDa Afu5g13300 aspartic endopeptidase Pep1
Asp f11 AJ006689 19.5 kDa Afu2g03720 cyclophilin type peptidyl-prolyl isomerase
Asp f12 U92465 50.5 kDa (80.3 kDa) Afu5g04170 Heat shock protein hsp90 family
Asp f13 AJ002026 15.9 kDa Afu2g12630 allergen 13/cerato-platanin (protease)
Asp f17 AJ224865 19.4 kDa (27.3 kDa) Afu4g03240 galactomannoprotein MP1/B-glucanase
Asp f18 Y13338 52.6 kDa Afu5g09210 alkaline serine protease Alp2
Asp f22 AF284645 47.3 kDa Afu6g06770 enolase
Asp f23 Q8NKF4 44.4 kDa Afu2g11850 60S ribosomal protein L3
*Asp f1 cDNA could not be cloned downstream of the pTrc promoter in pTrcHis2.
#Molecular sizes in bold correspond to the full length protein.
Proteins in bold were successfully expressed in E. coli.
doi:10.1371/journal.pone.0009036.t001
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attempts to increase production to levels amenable for bioassays
were unsuccessful.
Recombinant Asp f12 was prone to aggregation and precipi-
tation, and subsequently purified by Ni
2+ chelate chromatography
as per the other recombinant Asp f proteins (Materials and
Methods), but under denaturing conditions in the presence of 6 M
guanidine HCl (Sigma Aldrich) according to established protocols
[13,14]. The remaining Asp f proteins (Asp f3, Asp f6, Asp f9, Asp
f11, Asp f17, and Asp f22) were readily expressed at high levels in
E. coli (Figure 1); these 7 proteins were used in subsequent assays to
measure T cell responses.
Healthy Humans’ Response to Crude and Recombinant
Af Antigens
PBMC from 20 healthy individuals were tested against a panel
of seven E.coli-expressed recombinant Af antigens (Asp f3, Asp f6,
Asp f9, Asp f11, Asp f12, Asp f17 and Asp f22) and crude hyphal
extract (CHE) using ELISPOT. Healthy donors’ PBMC exhibited
variability of IFN-c and IL-4 responses, as shown by robust or
weak responses to A. fumigatus antigens (i.e. SFU varying from zero
to 80, Figure 2a, b). Few IL-17 producing cells were detected using
this assay, from any donors (Figure 2c).
All recombinant proteins elicited some measurable IFN-c
producing cells, although the range of SFU varied widely
(Figure 2a). rAsp f3, rAsp f11, rAsp f12, and rAsp f17 elicited
detectable IL-4 producing cells, although the numbers were low in
most donors (Figure 2b). Crude hyphal extract (CHE) induced
weak IFN-c, IL-4, and IL-17 responses when compared to all
recombinant proteins (Figure 2a–c).
Table 2 demonstrates the relative quality of responses (strong,
weak, and none) among 20 volunteers. Few donors exhibited
strong IFN-c responses to CHE; in contrast, rAsp f3, rAsp f9/16,
rAsp f11 and rAsp f22 elicited relatively higher IFN-c production.
These antigens did not induce IL-4 producing cells from the same
donors; few recombinant antigens were associated with the strong
IL-4 responses. None of the volunteers had strong IL-17 responses
to the antigens tested, although some people had small numbers of
measurable IL-17 circulating cells, particularly in response to
CHE and rAsp f3 (Table 2).
The repertoire of antigen recognition was characterized in 20
volunteers (Figure 3). Four of 20 donors (H4, H7, H11 and H13)
had strong IFN-c responses to all of the recombinant Af antigens
(Figure 3a). In donor H7, IL-4 secreting T-cells were also strong
after challenges with all rAsp f proteins, however, measured
responses were weaker when compared to IFN-c (Figure 3a, b).
CHE stimulated IFN-c producing cells strongly in donors H4 and
H7; two subjects (H2 and H19) had strong CHE-induced IL-4
responses (Figure 3a, b). Weaker IL-17 responses (ELISPOTs
,20, varying from 10–18 spots) were observed with rAsp f11 in
donors H11, H12, H13 and H17 (Figure 3c). Overall, these data
suggest that the repertoire of T cells that recognize Aspergillus
antigens is diverse, with variable antigen specificity; no obvious
immunodominant antigens were identified, although certain
recombinant Asp f proteins were more frequently associated with
strong IFN-c responses.
Stability of IFN-c responses were examined in a subset of strong
responders, using PBMC collected at different time points,
separated by 6 months. The two strongest antigens stimulating
IFN-c producing cells, rAsp f3 and rAsp f9/16, were tested
(Figure 4a). Strong responses were maintained in 5 of 7 donors
(H3, H5, H7, H13, and H15) in response to rAsp f3. Four of six
donors (H5, H7, H10, and H16) also had stably strong responses
after rAsp f9/16 challenge (Figure 4b).
Recombinant Asp f3 and Asp f9 Are Recognized by Both
CD4+ and CD8+ T-Cells
Negative selection was performed to determine whether IFN-c
producing cells comprising responses to rAsp f3 and rAsp f9/16
were CD4+ or CD8+. Donors who exhibited the strongest
responses were tested (Figure 5). Only one of eight strong
responders tested to rAsp f3 had single lineage CD4+ responses
(H13), and all seven tested to rAsp f9/16 had mixed CD4+ and
CD8+ T cells (Figure 5).
Discussion
CD4+ T lymphocytes are important mediators of host
inflammatory/anti-inflammatory responses, with the balance
between TH1/TH17 and TH2 phenotypes dictating disease
pathology. Aspergillus fumigatus enters the airway as conidia, which
are not inflammatory, until loss of a hydrophic coat [1–4]. In the
presence of inadequate clearance, organisms germinate into
hyphae, which expose multiple cell-associated and soluble
products that are recognized to promote inflammation and to
serve as antigens/allergens in the resultant early- and late-phase
inflammatory reactions [15]. Chronic inflammatory diseases result
in response to certain inhaled allergens, which are processed to T
cells that exhibit a predominant TH2 phenotype, leading to Ig
subtype switching and IgE synthesis, mast cell degranulation,
eosinophilia, mucus metaplasia and airway hyperresponsiveness.
Multiple microbial factors promote development of TH2-inflam-
mation, including the influence of certain microbial adjuvants
during antigen presenting cell activation, and the nature of the
protein itself. Aspergillus ‘allergens’ have been detected as proteins
recognized in patients who have hypersensitivity syndromes;
results of this study suggest that at least some of these proteins
are not strictly allergens, but induce TH1 cytokine responses in
Figure 1. Recombinant Asp f proteins expressed in E. coli. SDS-
PAGE of Asp f3, Asp f6, Asp f9/16, Asp f11, Asp f12, Asp f17, and Asp f22
produced in E. coli with C-terminal c-myc and His6 tags. Each lane
contains one microgram of protein. Triangles identify Asp f proteins.
Asp f22 appears as a doublet due to loss of the C-terminal tags in the
faster migrating protein species. Molecular size standards (SeeBlue
Plus2 Pre-Stained Standards, Invitrogen) are shown at left in kD.
doi:10.1371/journal.pone.0009036.g001
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of hyphal proteins to activate both protective and non-protective
inflammation.
Most A. fumigatus proteins that serve as allergens have been
identified from screens identifying proteins that bind IgE antibody
or, less commonly, stimulate CD4+TH2 clones in people with
asthma or ABPA [16]. These allergens have been classified as
having multiple diverse putative functions, including activity in
hydrolysis and breakdown of local tissues, transport, and
regulatory heat-shock proteins [16]. Structure-function properties
of Aspergillus allergens have not been defined; it is possible that
many of these proteins are distinguished as allergens by virtue of
the abundance of in vivo expression, and structural presence of B-
cell and T-cell epitopes. Results of this study show that healthy,
non-atopic people also have a variable, and diverse profile of
circulating TH1-producing CD4+ and CD8+ T cells that
recognize Asp f products. Hence, the human T cell repertoire to
this fungus appears diverse, but with a predilection towards
responses developed to hyphal and soluble products. These
findings are consistent with the current paradigm in which that
nature of CD4+ responses (TH1–TH17 vs. TH2) are largely
dictated by the inflammatory milieu, not singularly the function of
the expressed antigen per se.
Proteomic data suggests that some Asp f proteins are highly
expressed by mycelia in vitro [10]. Three of the 7 Asp f products that
elicited strong TH1 type responses in healthy subjects screened here
(Asp f3, Asp f12, and Asp f22) are some of the most highly abundant
proteins expressed by mycelia. Henc e ,i ti sl i k e l yt h a ta ts o m ep o i n ti n
life, these healthy volunteers were exposed to hyphal products, yet
did not develop overt pulmonary invasive or allergic disease.
Interest in establishing assays to measure Aspergillus-specific
immune reconstitution has been increased in recent years, with
recent studies demonstrating the importance of TH1-type CD4+ T
cells in mediating protection and recovery from invasive
Figure 2. ELISPOT assays using A. fumigatus crude hyphal extract (CHE) and purified recombinant antigens. (a) IFN-c (b) IL-4 and (c) IL-
17 ELISPOT assay. Blood was collected from 20 healthy donors and triplicate samples of 1610
5 (IFN-c)o r2 610
5 PBMCs (IL-4 or IL-17) were stimulated
with medium, 5 mg/ml phytohemoagglutinin (PHA) or 1 mg/ml CHE or recombinant A. fumigatus antigens for 24–48 hrs at 37uC/5%CO2. The mean
antigen-specific spot forming cells, SFC (after background subtraction of control wells with no antigen) is plotted. The median for each set of healthy
individuals is indicated by a bar. The figures show one representative data from three independent experiments.
***P,0.001,
** P,0.01 versus CHE
stimulated PBMC.
doi:10.1371/journal.pone.0009036.g002
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immunodominant antigens to enable accurate measurement of
protective responses- and to potentially develop immunotherapies-
has been elusive. Many studies have used crude hyphal extracts or
antigen formulations to measure PBMC responses or to generate
antigen-specific cell lines [20,21]. Results of studies shown here
suggest that these formulations may be suboptimal in measure-
ment of PBMC responses. This is consistent with results from
Stanzani et al., who reported that healthy donors demonstrate
weak functional T-cell responses to A. fumigatus crude extracts [22].
Hyphal extracts contain gliotoxin, an immunosuppressive myco-
toxin, which induces apoptosis of antigen-presenting cells and
inhibits transcription factor NF-kB [22–24] As these formulations
contain multiple microbial adjuvants (b-glucan, chitin) and
inhibitory molecules, standardization of antigen preparations is
necessary to allow for reproducibility and transparency in study
results.
While we observed that healthy volunteers have circulating
CD4+ and CD8+ T cells reactive to multiple recombinant
proteins, we do not know which proteins, if any, are ‘protective’
or dominant in the human T cell repertoire. However, studies in
animal models and humans suggest that the two gene products
eliciting most robust strong responses in healthy volunteers (Asp f3
Table 2. IFN-c, IL-4 and IL-17 T-cell responses of healthy
donors (n=20) to CHE and recombinant antigens of A.
fumigatus.
Antigens IFN-c IL-4 IL-17
SR WR NR SR WR NR SR WR NR
CHE 251 3 2 9 9 01 2 8
rAsp f3 10 9 1 0 14 6 0 12 8
rAsp f6 41 6 00 0 2 0011 9
rAsp f9/16 1 1 900 2 1 8041 6
rAsp f11 71 1 23 4 1 3091 1
rAsp f12 41 4 22 7 1 1081 2
rAsp f17 4881 6 1 3081 2
rAsp f22 61 4 00 0 2 0021 8
Strong responders (SR) were defined $20 SFU/10
5 cells, weak responders
,20 SFU/10
5 cells. NR = no SFU quantified. Data are derived from means of
triplicate measurements in three independent experiments.
doi:10.1371/journal.pone.0009036.t002
Figure 3. A. fumigatus antigens recognition by 20 healthy donors. (a) IFN-c (b) IL-4 and (c) IL-17 responses. Blood was collected from 20
healthy donors and triplicate samples of 1610
5 PBMCs were stimulated with medium, 5 mg/ml PHA or 1 mg/ml CHE or recombinant A. fumigatus
antigens for 24–48 hr at 37uC/5%CO2. The mean antigen-specific spot forming cells, SFC (after background subtraction of control wells with no
antigen) is plotted.
doi:10.1371/journal.pone.0009036.g003
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Naı ¨ve immunocompetent mice immunized with viable A. fumigatus
conidia had IgG antibodies predominantly to Asp f3 antigen [25].
The Asp f3 gene (a putative peroxismal membrane protein) is
homologous to the protective and dominant Coccidioides posadasii
antigen pmp1 [26]. Also, in this study, recombinant antigen Asp f9
(mistakenly identified as Asp f16 in earlier studies) induced IFN-c
responses with weaker recognition by IL-4 or IL-17-secreting T-
cells. Using murine models of invasive aspergillosis, Bozza et al
have shown that intranasal delivery of Asp f9 (reported as Asp f16)
with unmethylated CpG oligodeoxynucleotides induces protective
TH1 response against A. fumigatus [27]. Dendritic cells pulsed with
overlapping pentadecapeptides from Asp f9 (reported as Asp f16)
induced IFN-c secretion by both HLA-class I and class II-
restricted T-cells in humans [28,29]. Finally, a recent study by
Bozza and colleagues found that Asp f9 gene product (Crf1p,
Afu1g16190) appeared to retain an immunodominant TH1/Treg
activating potential in both mice and healthy humans [4].
There are likely to be multiple other secreted and membrane-
associated molecules that are sensed by human CD4+ T cells
during development of a protective response. Bozza and colleagues
described Cat1p and Pep1p (Asp f10) and the anchored protein
Gel1p as highly recognized by human IFN-c CD4+ T cells [4].
We also observed that the A. fumigatus enolase, rAsp f22, was
recognized exclusively by IFN-c secreting T-cells. Asp f22 is
known to have a homologue in C. albicans that has been reported to
induce protective response against systemic candidiasis in mice
[30,31]. More studies are necessary to fully characterize the
human T cell repertoire in healthy and allergic people.
The cohort contained strong responders to rAsp f3 and rAsp f9,
with both CD4+ and CD8+ T cell responses suggesting both HLA
class I and class-II restricted epitopes in these antigens. DCs cross-
present fungal antigens to stimulate protective and damaging CD8
T cell responses to multiple fungal pathogens, including Pneumo-
cystis species, Cryptococcus species, and Histoplasma capsulatum, among
others [11,32,33]. CD8+ T cells are recruited to the lungs in the
context of A. fumigatus-induced inflammation [34], although the
function of cytotoxic T cells in anti-Aspergillus immunity and
mediating the inflammatory/anti-inflammatory balance is not
Figure 4. IFN-c stability assay with rAsp f3 and rAsp f9 after
period of 6 months. To determine whether the IFN-c responses are
stable over time, blood was collected from high responders after six
month interval of previous assay and triplicate samples of 1610
5 IFN-c
PBMC were stimulated with medium and 1 mg/ml rAsp f3 (a) or rAsp f9
(b) for 18–24 hrs at 37uC/5%CO2. The mean antigen-specific spot
forming cells, SFC (after background subtraction of control wells with
no antigen) 6 SD is shown. The figures show one representative data
from three independent experiments.
doi:10.1371/journal.pone.0009036.g004






5) were isolated from strong
responders’ PBMC, incubated with 1 mg/ml of (a) rAsp f3 and (b) rAsp
f9 with autologous irradiated PBMC (5610
4) in triplicates for 24 hr at
37uC/5% CO2. PHA (5 mg/ml) was used as a positive control. The mean
antigen-specific spot forming cells, SFC (after background subtraction
of control wells with no antigen) 6 SD is shown.
doi:10.1371/journal.pone.0009036.g005
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Asp f9 (reported as Asp f16) induced IFN-c producing CD4
+ and
CD8
+ T-cells, respectively with cytotoxicity to Af culture filtrate-
pulsed target cells have been reported [28,29].
It is assumed that most healthy donors have roughly equivalent
exposure to hyphal antigens, in a dynamic daily process of conidial
airway clearance. However, we measured great variability in the
quantity, and quality of the T-cell responses to A. fumigatus
recombinant antigens. This observation is consistent with results of
multiple studies implicating genetic haplotypes and/or polymor-
phisms in mediating innate and acquired immunity. For instance,
responses may be attributed to the specific HLA-haplotypes
or polymorphisms in other genes whose products influence
the inflammatory nature of early innate immune responses (e.g.
TNF-a, TLR4) [35–37].
The quantity of measured Aspergillus-specific ELISPOT respons-
es in this healthy cohort are not robust when compared to select
viral antigens such as cytomegalovirus, in which CMV-seropos-
itive people develop higher quantities of measurable IFN-c
producing cells, in a dynamic interplay between intermittent viral
reactivation and augmentation of immunity [38,39]. However, the
bulk of donors tested did show relative stability of ‘‘strong’’
responses when tested over time. While variation of responses may
be caused by time-dependent changes in antigen exposure, this
would be difficult to measure. More studies need to be performed
to determine the relative kinetics of responses, and implications in
the context of secondary immunosuppression.
There are limitations to the conclusions that can be drawn in
this study. Only a few allergens were tested, in a relatively small
cohort of healthy volunteers. Also, we were unable to express some
products in the E. coli system, despite multiple attempts to
minimize potential cytotoxicity and proteolytic activity. Many of
the products that were not expressed are putative proteases, which
would have been of particular interest given functional associations
between protease activity and TH2 immunity [40]. High level
expression of some products has been achieved in a Baculovirus
system [41], in E. coli using a pET 23b (+) vector [27,42], and in S.
cerevisiae [4]. Further studies are warranted as lack of glycosylation
may alter the quantity or nature of responses measured. While
preparations were confirmed to contain ,0.1 EU/mL endotoxin,
there exists a possibility that low (not measurable) amounts of LPS
could function to induce nonspecific responses. We believe that
this is unlikely as E. coli protein controls did not elicit responses.
In summary, results of this study demonstrate that some
Aspergillus allergens function as antigens to TH1-directed CD4+
and cytotoxic T cells, with healthy volunteers demonstrating a
diverse repertoire to multiple hyphal expressed proteins. This
supports the paradigm in which local inflammatory responses, and
the nature of chronic immunity, is tailored by multiple microbial
and host variables dictating functional phenotypes. Identification
of dominant and protective antigens, and development of robust
assays for performance of immune reconstitution studies awaits
further studies.
Materials and Methods
Peripheral Blood Mononuclear Cell Isolation of Healthy
Humans
Healthy donor blood samples were obtained under protocols
approved by the Fred Hutchinson Cancer Research Center,
Oregon Health and Sciences University, and Johns Hopkins
University Institutional Review Boards following written informed
consent. Peripheral blood was drawn from 20 healthy donors
(Men=11, Women=9), between the ages of 27 to 46 years. No
volunteers had a history of suspected or proven fungal infection or
reported allergy/atopy. Peripheral blood mononuclear cells
(PBMC) were separated by use of Ficoll-Hypaque density gradient
centrifugation (Histopaque-1077, Sigma, St Louis, MO), washed
twice in phosphate-buffered saline (PBS) (GIBCO Invitrogen
Corp.), and resuspended with RPMI-1640 medium supplemented
with 10% Fetal Bovine serum (GIBCO Invitrogen Corp.) and
penicillin-streptomycin (GIBCO Invitrogen Corp.). All cell
preparations were more than 95% viable as judged by trypan
blue exclusion.
Isolated PBMC were suspended in cold freezing medium
(10%DMSO/90%FBS) at a density of 5–6 million cells per ml,
and aliquots were frozen at 280uC for 24 hrs before transfer to
liquid nitrogen. To revive PBMC, cryovials were immediately
thawed in a 37uC water-bath, washed twice in 10% RPMI-media
and viability was assessed by trypan-blue exclusion. This method
yielded recovery of 90–95% cells from frozen PBMC.
Preparation of Aspergillus fumigatus Crude Hyphal Extract
(CHE)
A. fumigatus crude hyphal extract (CHE) was generated by
culture of Af293 isolate (sequenced strain provided by D. Denning,
University of Manchester, UK) (5 days, 37uC) in RPMI 1640
(+10% FCS). The hyphal mat was harvested, sequentially washed
with PBS, and lysed by mechanical disruption with glass beads in a
BeadBeater homogenizer (BioSpec Products, OK). The slurry was
subjected to paraformaldehyde (1%) for microbial inactivation.
Protein concentration was measured using the Bradford assay
(Coomassie Protein Assay, Pierce) according to manufacturer’s
instructions. The product was concentrated using an endotoxin-
free dialysis membrane with 5-kDa pore size (Pierce) to achieve a
final protein concentration of 800–1000 mg/ml.
Expression of Recombinant A. fumigatus Allergens in
E. coli
Candidate A. fumigatus proteins were identified at the www.
allergen.org database (Table 1). The sequence data for each
allergen was verified against the Af293 A. fumigatus genome (www.
sanger.ac.uk/Projects/A_fumigatus/) by BLAST analysis to
ensure that these proteins were not strain-specific, as many of
these antigens were initially identified and characterized as
allergens of strain ATCC 42202 [43].
PCR amplification and cloning of cDNAs proceeded as follows:
PCR oligonucleotides pairs were designed to amplify the entire (or
partial) cDNAs without start and stop codons to optimize
expression from pTrcHis2 (Invitrogen), and to fuse the C-termini
to a c-myc epitope and 6X-His tags within the vector. Total RNA
was prepared from Af293 grown in glucose minimal medium
(MMG) [44] for 48 hr at 37uC, using the TRIzol reagent
(Invitrogen), as per the manufacturer’s recommendations with a
slight modification (J.W. Bok and N.P. Keller, University of
Wisconsin, personal communication). After TRIzol phase separa-
tion, the aqueous phase was extracted once with equal volume of
phenol/chloroform/isoamyl alcohol (25:24:1), before RNA pre-
cipitation with isopropanol. Three milligrams of total RNA was
used to isolate mRNA by binding to oligo(dT) cellulose as per the
manufacturer’s recommendations (FastTrack 2.0, Invitrogen).
Four micrograms of poly A
+ RNA was subsequently used in a
cDNA synthesis reaction (Universal Riboclone System, Promega)
primed with oligo(dT) to generate double-stranded cDNA
templates. Each 50 mL PCR contained oligonucleotide pairs at
0.2 mM each, dNTPs at 0.2 mM each, MgCl2 at 1.5 mM,
approximately 1.0 ng of cDNA, 1.0 unit of Platinum Taq DNA
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generated by incubation in a thermal cycler for 2 min. at 94C,
followed by 35 cycles of 94C for 1 min., 55C for 1 min. and 72C
for 3 min. The reactions were terminated by a final extension of
72C for 12 min. and holding at 4C. Generation of amplicons of
the expected molecular sizes was verified by gel electrophoresis
and ethidium bromide staining as per usual methods [45]. The
resulting amplicons were subsequently cloned into pTrcHis2
TOPO, and propagated in E. coli TOP10 cells (Invitrogen). The
authenticity of the recombinant plasmids was verified by
sequencing the cloned DNA across the junction sites between
the insert and the vector.
Expression of His6-tagged proteins was induced in TOP10 E.
coli grown to an OD600 of 0.6 in Luria broth [45] at 37C with
1 mM IPTG for 4 hr. Post induction, the cells were collected by
centrifugation and stored frozen at 280C. Cell extracts were
prepared by suspending the cell pellets in 3.0 mL of B-Per II
Bacterial Protein Extraction Reagent (Pierce) with 1X Halt-EDTA
free protease inhibitor cocktail (Pierce), and incubating at room
temperature with rocking for 20 min. The cell debris was removed
by centrifugation (27k6g for 15 min. at 4C), and the clarified
extract was applied (100 mL) to three rows of a 96-well plate
harboring SwellGel Ni
2+ chelated discs (Pierce). The flow through
was reapplied to the nickel-chelate slurry and the second flow
through discarded. Remaining unbound proteins were removed
by washing the nickel resin 4X with 200 mL of 50 mM Tris-Cl
pH 8.0, 300 mM NaCl, and 50 mM imidazole. Bound proteins
were eluted by adding 100 mL of Tris-Cl pH 8.0, 300 mM NaCl,
250 mM imidazole and collecting the flow through. The elution
was repeated with new elution buffer, and the eluates pooled. The
samples were subsequently desalted by exclusion chromatography
over 5 mL Zebra Desalt spin columns, as recommended by the
manufacturer (Pierce). Recovery and purity of the recombinant
proteins were analyzed by SDS-PAGE (NuPAGE 10% or 12%
acrylamide gels, Invitrogen) and staining (Bio-Safe Coomassie
reagent, BioRad Laboratories, CA). Expression of the desired
proteins was confirmed by their predicted molecular sizes in SDS-
PAGs. Lastly, the samples were concentrated in Amicon
centrifugal filter devices (Millipore), and quantified by the
Bradford assay (Coomassie Protein Assay, Pierce) with BSA as
standard. The concentrated recombinant protein preparations
were deemed $80% pure by densitometric analysis of Asp f
protein bands in relation to contaminating E. coli proteins in SDS-
PAGE (data not shown). Gel electrophoresis images were captured
with a GelDoc-ItTS Imaging System (UVP, Upland, CA), and
manipulated with ImageJ processing and analysis software (http://
rsb.info.nih.gov/ij/). Proteins preparations were confirmed to
contain ,0.1 EU/mL using the Limulus amebocyte lysate (LAL)
reaction kit (E-Toxate; Sigma, St Louis, MO).
ELISPOT Assays
ELISPOT assays were performed as previously described [46].
Briefly, ELISPOT plates (Multiscreen-MAIPS4510, Millipore)
were coated using primary monoclonal antibodies against IFN-c
(Clone 1-D1K, MabTech, Sweden), IL-4 (82.4, MabTech,
Sweden) and IL-17 (clone eBio64CAP17, eBioscience, San Diego,
CA) at the concentration of 10 mg/ml in bicarbonate coating
buffer, pH-9.6. PBMC (1610
5 cells/well for IFN-c and
2610
5 cells/well for IL-4 and IL-17) in 10% RPMI media were
added to the wells. Crude hyphal extract (CHE) and recombinant
A. fumigatus antigens (Asp f3, Asp f6, Asp f9, Asp f11, Asp f12, Asp
f17, and Asp f22) were added at the final concentration of 1 mg/
ml, while cells alone were considered as negative control.
Phytohemoagglutinin (PHA) was added at the concentration of
5 mg/ml as a positive control. IFN- c ELISPOT plates were
incubated at 37uC/5%CO2 for 24 hr, and IL-4 and IL-17 plates
were incubated for 48 hr. Secondary antibodies to IFN- c, IL-4
and IL-17 were added, and ELISPOT plates were developed using
BCIP/NBT solution (MabTech, Sweden). Plates were dried and
spots were enumerated using a Bioreader 4000 (Pro-X, BIOSYS
GmbH, Germany). Results are shown as mean antigen-specific
spot forming cells (SFC) after background subtraction of control
wells containing no antigen.
To further characterize T cell responses to certain antigens,
CD4+ and CD8+ T cells were purified from PBMC by negative
selection using magnetic beads, according to manufacturer’s
instructions (Miltenyi Biotech, Auburn, CA). Purity was more




5) were incubated with autologous irradiated
PBMC (5610
4) in triplicates with PHA (5 mg/ml) or recombinant
antigens (1 mg/ml) for 24 hr at 37uC/5% CO2.
Statistical Analysis
Statistical analyses were performed using Prism statistical
software (version 5.01; Graph-Pad Software, San Diego, CA).
Nonparametric two-tailed Mann-whitney test was used to
compare quantitative values. All P values were considered
significant if less than 0.05. The data reported was pooled from
three independent experiments, unless specified otherwise.
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